Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.32182 | 12 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.30579 | 12 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.30893 | 12 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.26402 | 12 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.25947 | 12 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.4829 | 17 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.51041 | 20 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.2906 | 12 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.28117 | 12 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.30413 | 13 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.30136 | 13 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.28852 | 13 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.319 | 13 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.30646 | 13 |